In recent weeks, I have witnessed first-hand the conflicts unfolding within health care organisations and have heard of even more from others. The tension is palpable, enough to incise with a scalpel.
At the heart of it all is a deceptively simple question: how much should health care cost?
Malaysian health care is often described as a two-tiered system. The first is the public health care system, funded principally by the government, prioritising access, equity, and population-level needs.
The second is the private health care system, funded instead by patients, employers, insurers, and other third-party payors, designed around different priorities: speed, choice, comfort, and clinical options. Priorities that a publicly funded system cannot reasonably provide for everyone.
Both systems matter. They are not, and should not, be enemies. Neither should be treated as morally superior to the other. Indeed, they often work together to improve patient outcomes.
Malaysia’s public health care is one the nation can be proud of. This is not blind patriotism. For decades, it has delivered outcomes that exceed those of many countries at similar levels of development.
These include improvements in neonatal and infant outcomes, maternal mortality, vaccine coverage, infectious disease control, and average life expectancy.
It has endured multiple crises while continuing to serve as a safety net for all Malaysians, regardless of socioeconomic status.
Our pride, however, should not prevent honesty. Public health care is under tremendous strain, its expansion outpaced by a population that is growing older, sicker, yet more medically literate and demanding than ever. The burden of non-communicable diseases grows heavier, and hospitals face occupancy pressures, staff shortages, and long waiting times.
These strains are not the failure of public health care alone. They are the predictable result of a system forced to broaden access with finite resources. Our safety net has been stretched up to, and perhaps beyond, reasonable limits.
Private health care, on the other hand, has historically played a different role. It does not maintain the same population-level focus, nor does it see the same volumes as the public system, and it does not function as a default safety net.
Instead, it serves those who can pay directly, those whose employers fund their care, and those who pay a premium to insurance companies for an experience with less friction relative to what the public system is able to offer.
The difference is not merely about nicer rooms and shorter queues. At its best, private health care provides options. Patients can choose doctors. Access to elective care is quicker. Private hospitals can invest in newer technologies, drugs, and implants that may enable alternative treatment strategies, surgical techniques, and better outcomes.
They provide a different service model, one that is more responsive to changing needs. In doing all this, it serves as a release valve for the public health care system, and as an early adopter of innovations that may later diffuse more widely.
This traditional boundary, however, is shifting.
As pressure on public hospitals has grown, so has the incentive for patients and employers to seek private coverage. Patients who once relied exclusively on the public system are now looking to private hospitals instead, not because they have suddenly become wealthy, but because they hope to avoid long waits and uncertainty.
They fear the public system may no longer provide what they need, when they need it. This may have increased private patient volumes, while also shifting the sector’s priorities and power dynamics.
Although private health care has long depended on self-paying patients, employer benefits, and insurance, the balance of influence appears to be shifting. Payors are no longer merely reimbursing care after the fact. They increasingly shape what care is approved, what products are used, and what costs are considered acceptable. In effect, payors are becoming more than financiers – they are becoming allocators of care.
To be clear, payors are not wrong to worry about cost. Health care inflation is real. Unchecked bills lead directly to higher premiums, reduced coverage, and increases in exclusions and co-payments. Waste should be challenged. Unnecessary investigations and over-servicing should be questioned, not blindly defended under the banner of clinician autonomy.
Yet cost itself must be examined with care. There are crucial differences between static efficiency and dynamic efficiency. Static efficiency asks how an episode of care can be delivered at the lowest reasonable cost today.
It is concerned with the here and now: immediate bills, standardisation, and reimbursement discipline. These are not trivial concerns, of course. In fact, in a system facing health care inflation and rising premiums, they are necessary.
But dynamic efficiency asks a different question: how does the system preserve its ability to improve tomorrow? How can it create space for newer treatments, better implants, improved surgical techniques, digital systems, service innovations, and more?
A system optimised purely for today’s lowest bills may reduce immediate costs while quietly eroding the conditions that allow tomorrow’s care to improve.
This is where the pendulum risks swinging too far. For years, private health care may have tolerated too much variation, while payors had too few mechanisms to scrutinise whether every intervention truly added value. A correction was necessary.
But if that correction takes the form of an unthinking, universal preference for the cheapest reimbursable option, then we have not achieved value-based care. We have merely replaced one form of distortion with another.
There is a profound difference between removing waste and reducing care to the lowest reimbursable denominator. If private health care is forced to use, by default, only what is cheapest, most standardised, and easiest to justify to payors, its role begins to change. It becomes less of an alternative system and more of a parallel delivery channel for minimum acceptable care.
The room may still be more spacious, the queues shorter, and the consultants may still be chosen by the patient. But most crucially, the care itself begins to converge with that of a system built around scarcity rather than innovation.
Public health care, by its very remit, must make utilitarian decisions. It must ask what produces the greatest benefit for the greatest number within its limited budget. This is not just sensible, but entirely unavoidable.
But private health care has traditionally operated on a different logic. Its purpose was never to replace public health care, but neither was it meant to abandon all cost discipline. Instead, its purpose is to provide a space where patients have choice, where clinicians have room to provide individualised care, and where providers can be incentivised to continuously differentiate, improve, and innovate.
The value of private health care lies not in providing health care differently, but in complementing the public system by doing things it cannot reasonably be expected to do.
If the same logic of rationing under scarcity that governs public health care is imported without consideration into private health care through payor pressure, we risk weakening both systems. Public health care, without fundamental reforms, will remain overcrowded and underfunded.
Meanwhile, private health care becomes less distinctive, less innovative, and less able to relieve pressure from its public counterpart. What happens then is not genuine integration, but convergence under mutual constraints.
The challenge is therefore not the choice between affordability and innovation. It is ensuring that our pursuit of one does not quietly extinguish the other.
Dr Ng Kuo Chern is a medical doctor with an MBA and works in hospital operations, where he is involved in service delivery, organisational improvement, and value-driven outcomes. He writes on health care systems, economics, and policy in his personal capacity. The views expressed in this article are the author’s own and do not represent those of his employer or any affiliated organisation.
- This is the personal opinion of the writer or publication and does not necessarily represent the views of CodeBlue.
